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Herein, we report the extracellular expression of carbohydrate
active fusion enzymes in Pichia pastoris. Particularly, CBM29-1-2
from Piromyces equi was separately fused to the N- and C-terminus
of galactose 6-oxidase (GaO, D-galactose: oxygen 6-oxidor-
eductase, EC 1.1.13.9, CAZy family AA5) from Fusarium grami-
nearum, generating CBM29-GaO and GaO-CBM29, respectively. P.
pastoris was transformed with expression vectors encoding GaO,
CBM29-GaO and GaO-CBM29, and the fusion proteins were
expressed in both shake-ﬂask and 2L bioreactor systems. Volu-
metric production yields and speciﬁc GaO activity increased when
expression was performed in a bioreactor system compared to
shake-ﬂask cultivation. This was observed for both CBM29-GaO
and GaO-CBM29, and is consistent with previous reports of GaO
expression in P. pastoris (Spadiut et al., 2010; Anasontzis et al.,
2014) [1,2]. Fusion of CBM29 to the C-terminal of GaO (GaO-
CBM29) resulted in a stable uniform protein at the expected cal-
culated size (107 kDa) when analyzed with SDS-PAGE. By com-
parison, the expression of the N-terminal fusion protein (CBM29-
GaO) was low, and two truncated versions of CBM29-GaO were












F. Mollerup, E. Master / Data in Brief 6 (2016) 176–183 177protein yield, the speciﬁc GaO activity on galactose was not
affected by CBM29 fusion to either the N- or C-terminus of the
enzyme. A detailed description of the catalytic and physiochemical
properties of CBM29-GaO and GaO-CBM29 is available in the
parent publication (Mollerup et al., 2015) [3].
& 2015 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Speciﬁcations Tableubject area Biochemistry and Recombinant Protein Production
ore speciﬁc sub-
ject areaRecombinant protein expression of fusion proteins in Pichia Pastorisype of data Tables and Figures
ow data was
acquiredThrough analysis of data from recombinant protein expressionata format Data is analysed and presented in text
xperimental
factorsRecominant expression and puriﬁcation of fusion proteins constructed by
separately appending a family 29 carbohydrate binding module to the N- and C-
terminus of galactose oxidasexperimental
featuresProtein expression in shake-ﬂasks and bioreactor systems and chromatographic
methods to purify target proteins from cell culture supernatantsata source
locationNot applicableata accessibility Data is accessible in this article and upon request to the authorsValue of the data1. These results represent the ﬁrst production and puriﬁcation study of galactose oxidase fusions to
non-native carbohydrate binding modules, and investigates the impact of CBM positioning on
protein recovery.
2. To our knowledge, these expression data present the most active preparation of GaO puriﬁed from
a P. pastoris expression host, and simultaneously demonstrate the advantages of using a bioreactor
over shake-ﬂask cultivations.
3. Observation of truncated forms of CBM29-GaO, which co-expressed with the full-sized protein. All
versions bound efﬁciently to a Ni-NTA column through a C-terminal His6-tag.
4. Isolation of full-sized CBM29-GaO from its truncated versions by ion-exchange chromatography
utilizing slight differences in calculated pI values.1. Data, experimental design, materials and methods
1.1. Expression of GaO constructs in shake-ﬂasks
The expression vector, fusion protein sequences, and transformation method are reported in
Mollerup et al. [3]. Pichia pastoris transformants encoding CBM29-GaO or GaO-CBM29 for extra-
cellular expression were grown overnight in 300 mL buffered minimal glycerol medium (BMGY (w/v):
1% yeast extract, 2% peptone, 100 mM potassium phosphate buffer (pH 6.0), 1.34% YNB, 4105%
biotin, 1% glycerol) at 30 °C with continuous shaking at 250 rpm. Cells were harvested by
centrifugation (1500g) at room temperature and suspended in buffered minimal methanol med-
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yeast nitrogen base without amino acids (YNB), 4105% biotin, 0.5% methanol, 0.004% histidine) to
OD600 2.0. Cultures were grown at 15 °C for 4 days, and 0.5% methanol was added every 24 h to
induce recombinant protein expression. Culture supernatants containing the recombinant protein
were harvested by centrifugation at 3000g for 30 min and ﬁltered through 0.22 μm PES ﬁlter mem-
brane (GE Healthcare – Life Sciences) before puriﬁcation (see below).
The activity of wild-type GaO and GaO fusions was measured using the previously described
chromogenic ABTS (2,20-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid)) assay [4]. The standard
reaction mixture (ﬁnal volume: 200 μL) contained 7 U/mL horseradish peroxidase, 2 mM ABTS, and
300 mM galactose in 50 mM sodium phosphate buffer (pH 7.0); reactions were then initiated by
adding 5 μL of the enzyme sample diluted to accurately measure initial reaction rates. Reactions were
monitored at 420 nm at 30 °C for 3 min. Hydrogen peroxide (from 5104 to 5102 μmole) was
used to generate a standard curve. Each reaction was performed in triplicate, at minimum.
Similar to studies reporting GaO production in P. pastoris [1], the addition of 0.5 mM copper sulfate
to P. pastoris shake-ﬂask cultivations increased GaO-CBM29 activity in the cultivation medium by
more than 2 times (Fig. 1).
1.2. Expression of GaO constructs in a bioreactor system
All fermentations were performed using a Biostat B Plus bioreactor (Sartorius) equipped with pH
and oxygen probes from Hamilton and connected to a MFCSwin process control system (BBI B. Braun
Biotech International). Cultivation conditions were based on Pichia Fermentation Process Guidelines
provided by Invitrogen, with minor modiﬁcations. Brieﬂy, a 100 mL inoculum of P. pastoris KM71H
(MutS) expressing wild-type GaO and P. pastoris SMD1168H (Mutþ) expressing GaO/CBM29 fusions
were cultivated in YPD at 30 °C to an OD600 between 2 and 6. Cells were harvested by centrifugation
(3000g, 5 min) and then suspended in basal salts medium (26.6 mL 85% phosphoric acid, 0.93 g
calcium sulfate, 18.2 g potassium sulfate, 14.9 g magnesium sulfate-heptahydrate, 4.13 g potassium
hydroxide, 40 g glycerol per liter). The initial fermentation medium comprised 1 L basal salts medium
containing 4% (w/v) glycerol and 0.435% (v/v) PTM1 trace salts (6.0 g cupric sulfate pentahydrate,
0.08 g sodium iodide, 3.0 g manganese sulfate monohydrate, 0.2 g sodium molybdate dihydrate,
0.02 g boric acid, 0.5 g cobalt chloride, 20.0 g zinc chloride, 65.0 g ferrous chloride heptahydrate, 0.2 g
biotin, 5.0 ml sulfuric per liter). The pH was controlled to pH 6.0 by automatic addition of 15% (w/v)
ammonium hydroxide, which also served as the sole nitrogen source during cultivation. The dissolved
oxygen concentration was maintained above 40% by automatic cascade stirring and gas ﬂow feed-
back-control, using the proportional–integral–derivative (PID) controller function in the bioreactor.
Speciﬁcally, the stirrer speed was ﬁrst increased from 300 to 1200 rpm and then the airﬂow was
increased from 0.5 to 3.0 L min1 until maximum oxygen transfer capacity of the reactor wasFig. 1. Cell density and volumetric galactose oxidase activity of GaO-CBM29 in shake-ﬂasks cultivations after ﬁrst induction. ■
Standard cultivation (pre-cultivation at 30 °C and induction at 15 °C); ♦ standard cultivation medium plus 10 μM leupeptin in
the induction medium,  pre-cultivation at 15 °C prior to induction; ● standard cultivation plus addition of 0.5 mM copper
sulfate to the induction medium.
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from the medium the glycerol fed-batch phase was initiated manually by feeding a 50% (w/v) glycerol
mix, with 1.2% (v/v) PTM1 trace salts, to the reactor at initially 15 mL h1, and stepwise increased
until the maximum oxygen transfer capacity was reached while still maintaining a substrate-limited
growth rate and dissolved oxygen concentration between 25% and 35% (though the feed rate was not
further increased once reaching a maximum of 25 mL h1).
For induction, the temperature was lowered to 20 °C, the glycerol feed was stopped, and the
dissolved oxygen concentration was allowed to increase as residual glycerol was consumed by the
cultures. To express fusion constructs from P. pastoris SMD1168H and GaO from P. pastoris KM71H,
methanol with 1.2% (v/v) PTM1 trace salts was added stepwise from 0.5%, to 1.0% and then 2.0%, while
allowing the dissolved oxygen to stabilize prior to the next methanol addition. In this way, cultures
were presumably acclimatized to methanol metabolism prior to feeding with methanol at a ﬂow rate
of 7.0 mL h1 for SMD1168 Mutþ strains and 2.7 mL h1 for the KM71H MutS strain. For all culti-
vations, DO was monitored to ensure that oxygen consumption was limited by methanol metabolism.
Production of the fusion constructs along with wild-type GaO in the bioreactor system allowed
better control of temperature, aeration, and methanol feed. Accordingly, the yield of puriﬁed CBM29-
GaO and GaO-CBM29 were more than 12 and 6 times higher than from shake ﬂasks; corresponding
speciﬁc activities also increased by 20% and 37%, respectively (Table 1), potentially due to impacts of
growth condition on functional folding and post-translational processing, and the presence of copper
(II) in the medium. These trends are consistent with a recent study aimed at optimizing GaO pro-
duction in bioreactor systems [2], and so these samples were used for all subsequent analysis.
1.3. Puriﬁcation of recombinant GaO
Protein in culture supernatants from shake-ﬂaks cultivations was precipitated using ammonium
sulfate (up to 70 (w/v)% of saturation at 4 °C). Protein pellets were recovered by centrifugation, dis-
solved in a minimal volume of 50 mM sodium phosphate buffer (pH 7.0), and then ﬁltered through a
Sterivex-GP 0.22 μm PES ﬁlter unit (Millipore). The resulting concentrates were separately incubated
overnight at 4 °C with 20 mL of 50% Ni-NTA resin (Qiagen) equilibrated in the same buffer. Each Ni-
NTA resin was then transferred into an empty XK-16/10 column (GE Life Sciences) resulting in a
packed bead volume of 10 mL. Protein with unspeciﬁc binding was washed from the Ni-NTA resin
using 10 column volumes (CV) of sodium phosphate buffer (pH 7.0). Fractions (5 mL) were eluted at a
ﬂow rate of 0.5 cm/min using a linear gradient of 0–100% Ni-NTA elution buffer (400 mM imidazole in
50 mM sodium phosphate buffer (pH 7.0)) over 10 CV. All chromatographic steps were performed at
room temperature using an Äkta chromatography system (GE Life Sciences). Fractions containingTable 1














GaO (wt) 68 P. pastoris
KM71
ND ND 104.2 516725
GaO-CBM29 107 P. pastoris
SMD1168
1.5 355.4723 13.6 487710
CBM29-GaO 107 P. pastoris
SMD1168
0.64 363.8732 1.4c 438729
a Yields refer to mg of puriﬁed enzyme (495%) per liter of cultivation medium.
b Speciﬁc activity of fully mature and active GaO, GaO-CBM29 and CBM29-GaO (Fig. 3 lane 10) was measured using
300 mM galactose; n¼3.
c Refers to ﬁnal yield of the 107 kDa protein (after EIX puriﬁcation (Fig. 3)). Puriﬁed yield of all the recombinant versions of
CBM29-GaO (70, 90 and 107 kDa) was 3.4 mg/mL.
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(pH 7.0) using a Vivaspin 20 unit (30,000 MWCO; GE Healthcare Life Sciences).
Puriﬁcation of wild-type GaO and fusion constructs from bioreactor cultivations were modiﬁed as
follows. At the end of each fermentation, the pH was automatically adjusted to 7.5 for puriﬁcation
using 4 M sodium hydroxide. This also resulted in precipitation of residual fermentation medium salts
in the medium. The supernatant was then harvested by centrifugation at 13,680g for 60 min at 4 °C,
adjusted to 1 M ammonium sulfate by dilution with a 4 M stock, and then ﬁltered through a 0.22 μm
PES ﬁlter unit. The pH was checked again before the protein solution was subsequently loaded onto a
10 mL phenyl sepharose FF column equilibrated to 50 mM sodium phosphate containing 1.0 M
ammonium sulfate, with a ﬂow rate of 2.5 cm/min. Weakly bound protein was removed using 5 CV of
the equilibration buffer, and then 50 mL fractions were eluted at a ﬂow rate of 2.5 cm/min using a
linear gradient of 1.0 M ammonium sulfate to 50 mM sodium phosphate buffer (pH 7.5) over 10 CVs.
As above, all chromatographic steps were performed at room temperature using an Äkta chroma-
tography system. CBM29-GaO and GaO-CBM29 were further puriﬁed using Ni-NTA afﬁnity resin as
described above. While this yielded a single protein band as visualized by SDS-PAGE that also cor-
responded to the expected size for GaO-CBM29, SDS-PAGE assessment of CBM29-GaO fractions
showed that two proteins co-eluted from the IMAC column (Fig. 2). To further separate CBM29-GaO
from putative truncated forms, fractions containing CBM29-GaO were desalted and adjusted to pH
7.0 in 50 mM sodium phosphate using a Vivaspin 20 (MWCO 30.000). The sample was loaded on a
1 mL DEAE-sepharose column (HiTrap DEAE FF, GE Life Sciences) with a ﬂow rate of 0.5 cm/min andFig. 2. Electrophoretic molecular weight of puriﬁed enzymes isolated from bioreactor cultivations. Lanes, 1: Precision Plus
PMWL, 2: GaO (untreated), 3: GaO (treated with CuSO4), 4: GaO-CBM29 (untreated), 5: GaO-CBM29 (treated with CuSO4), 6:
partially puriﬁed CBM29-GaO (untreated), 7: partially puriﬁed CBM29-GaOx (treated with CuSO4). Treated samples were
incubated for 120 h with CuSO4 at 4 °C. The complete assessment of CuSO4 on the recombinant enzymes is shown in Fig. 4 and
Table 2.
Fig. 3. Ion-exchange chromatography of CBM29-GaO to isolate the 107 kDa band from truncated versions coeluted from NiNTA
puriﬁcation. Lanes, 1: Precision Plus PMWL, 2: CBM29-GaO from lane 7 in Fig. 2 and 3: CBM29-GaO adjusted to 50 mM sodium
phosphate (pH 7.0), 4: ﬂow-through, 5–9 elutions with increasing sodium chloride concentration, 10: CBM29-GaO desalted in
50 mM sodium phosphate (pH 7.5).
Fig. 4. Electrophoretic molecular weight of puriﬁed enzymes following incubation in 0.5 mM CuSO4 at 4 °C. Sample identities
are indicated by the inserted legends.
Table 2
Relative enzyme activity following incubation at 4 °C in 50 mM sodium phosphate with or without 0.5 mM CuSO4. The activity
of reaction mixtures at 0 h that were subsequently amended with CuSO4 were deﬁned as 100%.
Incubation time (h) Relative activity (%)
GaO GaO-CBM29 CBM29-GaO
CuSO4 Buffer CuSO4 Buffer CuSO4 Buffer
0 100 90 100 101 100 97
0.5 107 109 99 92 69 75
1 101 96 89 99 68 81
2 104 97 83 94 72 79
4 109 95 84 100 81 85
18 116 97 84 99 85 80
93 105 85 79 82 54 60
F. Mollerup, E. Master / Data in Brief 6 (2016) 176–183 181eluted by an increasing concentration of sodium chloride (0–1 M), to then reach over 95% purity as
assessed by SDS-PAGE (Fig. 3).
In all cases, protein samples were transferred to 50 mM sodium phosphate buffer (pH 7.5) with
continuous dilution and concentration using a Vivaspin (MWCO 30.000 Da) before using the Bradford
method (Bio-Rad Laboratories, USA) to measure protein concentration and SDS-PAGE to conﬁrm
enzyme purity. Puriﬁed samples were then ﬂash frozen with liquid nitrogen and stored at 80 °C.
Fig. 5. Impact of potassium ferricyanide on GaO activity using enzymes puriﬁed from bioreactor cultivations. Approximately
7.5 μg (0.5 mg/mL) of protein was incubated for 15 min. at room temperature in presence or absence of 0.46 mM K4Fe(CN)6. The
samples where diluted 1000 times prior activity determination. ● samples in 50 mM sodium phosphate alone, ♦ samples
containing 0.46 mM K4Fe(CN)6.
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107 kDa, which is consistent with the predicted molecular mass of these enzymes (107.3 kDa) (Fig. 2).
Correspondingly, the yield of puriﬁed CBM29-GaO and GaO-CBM29 from shake-ﬂask cultivations
induced at 15 °C was 0.65 mg/L and 1.5 mg/L, respectively (Table 1). Enzyme identities were veriﬁed
by mass spectrometric analysis of tryptic fragments (Biomedicum, University of Helsinki).
1.4. GaO activation
To conﬁrm full activation of GaO, puriﬁed wild-type GaO and GaO fusions from bioreactor culti-
vations were treated with copper sulfate and potassium ferricyanide as previously described [4–6].
Speciﬁcally for this study, 0.15 mg/mL of puriﬁed enzymes were incubated in 0.5 mM copper sulfate
for up to 120 h (Fig. 2) at 4 °C. After 0.5, 1, 2, 4, 18, 93 and 120 h of incubation, samples were recovered
for SDS-PAGE analyses (Figs. 2 and 4) and activity measurement (Table 2) using the standard activity
assay. Puriﬁed enzymes were also separately treated with 0.46 mM potassium ferricyanide at room
F. Mollerup, E. Master / Data in Brief 6 (2016) 176–183 183temperature for 10 min and then analyzed for activity (Fig. 5). In all cases, enzymes were diluted to
0.15 mg/mL prior activity determination, and enzymes incubated in reaction buffer alone were used
as references.
Whereas adding copper sulfate to shake ﬂask cultivations doubled GaO activity measured in the
cultivation medium (Fig. 1), incubation of puriﬁed GaO-CBM29 and CBM29-GaO from bioreactor
cultivations with 0.5 mM copper (II) sulfate under aerobic conditions did not further increase the
speciﬁc activity of these enzymes (Table 2), or cause corresponding protein bands to shift when
observed by SDS-PAGE (Fig. 4). Similarly, treatment with 0.46 mM potassium ferricyanide did not
increase enzyme activities, suggesting that the puriﬁed wild-type GaO and fusion proteins were in the
fully oxidized and active state [Cu2þ-Tyr●-Cys] (Fig. 5).Acknowledgments
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